Estudio RAINBOW:
SG
9
10
Group 4/2 → 2/1
Group 2/1
y
6
7
8
Controls
vival probabilit
3
4
5
ession-free sur
SG 4/2
Æ
2/1 no alcanzada (SG a 36m 72,7%)
SG 2/1
23 m
SG 4/2
27,8 m
1
2
0
Progr
1
2
3
4
5
6
7
8
9
10
0
4/2 → 2/1
207
172
119
57
32
14
5
1
0
0
0
2/1
39
16
5
4
1
0
0
0
0
0
0
Follow-up time (years)
Number at risk*
Controls
211
141
82
50
29
20
10
5
2
1
0
*1 patient in the 4/2
Æ
2/1 group and 2 patients in the 2/1 group were not evaluable for OS
Bracarda S et al, Ann Oncol. 2015
